Spindletop Health Acquisition Corp. (NASDAQ:SHCA – Get Rating) was the target of a significant drop in short interest during the month of October. As of October 31st, there was short interest totalling 5,400 shares, a drop of 33.3% from the October 15th total of 8,100 shares. Based on an average daily volume of 40,900 shares, the days-to-cover ratio is presently 0.1 days.
Hedge Funds Weigh In On Spindletop Health Acquisition
Several institutional investors have recently bought and sold shares of SHCA. Progeny 3 Inc. bought a new position in Spindletop Health Acquisition during the first quarter valued at $14,940,000. Taconic Capital Advisors LP bought a new stake in shares of Spindletop Health Acquisition in the 1st quarter worth about $8,042,000. Aristeia Capital LLC bought a new stake in shares of Spindletop Health Acquisition in the 1st quarter worth about $4,990,000. Sculptor Capital LP lifted its holdings in shares of Spindletop Health Acquisition by 100.0% in the 1st quarter. Sculptor Capital LP now owns 1,000,000 shares of the company’s stock worth $9,960,000 after acquiring an additional 500,000 shares during the last quarter. Finally, Bank of America Corp DE bought a new stake in shares of Spindletop Health Acquisition in the 1st quarter worth about $4,980,000. Institutional investors own 97.03% of the company’s stock.
Spindletop Health Acquisition Stock Performance
SHCA stock opened at $10.14 on Friday. Spindletop Health Acquisition has a 52 week low of $9.55 and a 52 week high of $10.87. The company has a fifty day simple moving average of $10.07 and a two-hundred day simple moving average of $10.03.
Spindletop Health Acquisition Company Profile
Spindletop Health Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare services industry sector. The company was incorporated in 2021 and is based in Austin, Texas.
- Get a free copy of the StockNews.com research report on Spindletop Health Acquisition (SHCA)
- Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
- Six Flags is a Ride You Don’t Want to Get Stuck On
- Hanesbrands May be Signaling a Bad Week for Retail Stocks
- Vision Hydrogen, Now Vision Energy, Puts Hopes In Stock Split
- Coupang Stock And Why You Should Care
Receive News & Ratings for Spindletop Health Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spindletop Health Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.